Personal information

Verified email domains

Activities

Works (39)

Prospective isolation of mouse and human hematopoietic stem cells using Plexin domain containing 2

2021-09 | Preprint
Contributors: Tanaka Y; Kubota Y; Lieberam I; Barlow JL; Bramley JW; Sakuma C; Shibata T; Nakagawa M; Kurosawa Y; Maruyama T et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

IL-6 effector function of group 2 innate lymphoid cells (ILC2) is NOD2 dependent.

Science immunology
2021-05 | Journal article
Contributors: Hardman CS; Chen YL; Salimi M; Nahler J; Corridoni D; Jagielowicz M; Fonseka CL; Johnson D; Repapi E; Cousins DJ et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Mapping Rora expression in resting and activated CD4+ T cells.

PloS one
2021-05 | Journal article
Contributors: Haim-Vilmovsky L; Henriksson J; Walker JA; Miao Z; Natan E; Kar G; Clare S; Barlow JL; Charidemou E; Mamanova L et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

RORα is a critical checkpoint for T cell and ILC2 commitment in the embryonic thymus.

Nature immunology
2021-01 | Journal article
Contributors: Ferreira ACF; Szeto ACH; Heycock MWD; Clark PA; Walker JA; Crisp A; Barlow JL; Kitching S; Lim A; Gogoi M et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Group-2 innate lymphoid cell-dependent regulation of tissue neutrophil migration by alternatively activated macrophage-secreted Ear11.

Mucosal immunology
2020-05 | Journal article
Contributors: Panova V; Gogoi M; Rodriguez-Rodriguez N; Sivasubramaniam M; Jolin HE; Heycock MWD; Walker JA; Rana BMJ; Drynan LF; Hodskinson M et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Re-evaluation of human BDCA-2+ DC during acute sterile skin inflammation.

The Journal of experimental medicine
2020-03 | Journal article
Contributors: Chen YL; Gomes T; Hardman CS; Vieira Braga FA; Gutowska-Owsiak D; Salimi M; Gray N; Duncan DA; Reynolds G; Johnson D et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Rora regulates activated T helper cells during inflammation

2019-07 | Preprint
Contributors: Haim-Vilmovsky L; Henriksson J; Walker JA; Miao Z; Natan E; Kar G; Clare S; Barlow JL; Charidemou E; Mamanova L et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

A stromal cell niche sustains ILC2-mediated type-2 conditioning in adipose tissue.

The Journal of experimental medicine
2019-06 | Journal article
Contributors: Rana BMJ; Jou E; Barlow JL; Rodriguez-Rodriguez N; Walker JA; Knox C; Jolin HE; Hardman CS; Sivasubramaniam M; Szeto A et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Polychromic Reporter Mice Reveal Unappreciated Innate Lymphoid Cell Progenitor Heterogeneity and Elusive ILC3 Progenitors in Bone Marrow.

Immunity
2019-05 | Journal article
Contributors: Walker JA; Clark PA; Crisp A; Barlow JL; Szeto A; Ferreira ACF; Rana BMJ; Jolin HE; Rodriguez-Rodriguez N; Sivasubramaniam M et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

BET Bromodomain Inhibitor iBET151 Impedes Human ILC2 Activation and Prevents Experimental Allergic Lung Inflammation.

Frontiers in immunology
2019-04 | Journal article
Contributors: Kerscher B; Barlow JL; Rana BM; Jolin HE; Gogoi M; Bartholomew MA; Jhamb D; Pandey A; Tough DF; van Oosterhout AJM et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Innate Lymphoid Cells of the Lung.

Annual review of physiology
2019-02 | Journal article
Contributors: Barlow JL; McKenzie ANJ
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Roles for T/B lymphocytes and ILC2s in experimental chronic obstructive pulmonary disease.

Journal of leukocyte biology
2018-09 | Journal article
Contributors: Donovan C; Starkey MR; Kim RY; Rana BMJ; Barlow JL; Jones B; Haw TJ; Mono Nair P; Budden K; Cameron GJM et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

CD1a presentation of endogenous antigens by group 2 innate lymphoid cells.

Science immunology
2017-12 | Journal article
Contributors: Hardman CS; Chen YL; Salimi M; Jarrett R; Johnson D; Järvinen VJ; Owens RJ; Repapi E; Cousins DJ; Barlow JL et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Type-2 innate lymphoid cells in human allergic disease.

Current opinion in allergy and clinical immunology
2014-10 | Journal article
Contributors: Barlow JL; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

MHCII-mediated dialog between group 2 innate lymphoid cells and CD4(+) T cells potentiates type 2 immunity and promotes parasitic helminth expulsion.

Immunity
2014-07 | Journal article
Contributors: Oliphant CJ; Hwang YY; Walker JA; Salimi M; Wong SH; Brewer JM; Englezakis A; Barlow JL; Hams E; Scanlon ST et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

A role for IL-25 and IL-33-driven type-2 innate lymphoid cells in atopic dermatitis.

The Journal of experimental medicine
2013-12 | Journal article
Contributors: Salimi M; Barlow JL; Saunders SP; Xue L; Gutowska-Owsiak D; Wang X; Huang LC; Johnson D; Scanlon ST; McKenzie AN et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

IL-25 and type 2 innate lymphoid cells induce pulmonary fibrosis.

Proceedings of the National Academy of Sciences of the United States of America
2013-12 | Journal article
Contributors: Hams E; Armstrong ME; Barlow JL; Saunders SP; Schwartz C; Cooke G; Fahy RJ; Crotty TB; Hirani N; Flynn RJ et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

The TNF-family cytokine TL1A promotes allergic immunopathology through group 2 innate lymphoid cells.

Mucosal immunology
2013-12 | Journal article
Contributors: Meylan F; Hawley ET; Barron L; Barlow JL; Penumetcha P; Pelletier M; Sciumè G; Richard AC; Hayes ET; Gomez-Rodriguez J et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity.

PLoS pathogens
2013-10 | Journal article
Contributors: De Muylder G; Daulouède S; Lecordier L; Uzureau P; Morias Y; Van Den Abbeele J; Caljon G; Hérin M; Holzmuller P; Semballa S et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

IL-33 is more potent than IL-25 in provoking IL-13-producing nuocytes (type 2 innate lymphoid cells) and airway contraction.

The Journal of allergy and clinical immunology
2013-06 | Journal article
Contributors: Barlow JL; Peel S; Fox J; Panova V; Hardman CS; Camelo A; Bucks C; Wu X; Kane CM; Neill DR et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Innate lymphoid cells--how did we miss them?

Nature reviews. Immunology
2013-01 | Journal article
Contributors: Walker JA; Barlow JL; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Direct control of hepatic glucose production by interleukin-13 in mice.

The Journal of clinical investigation
2012-12 | Journal article
Contributors: Stanya KJ; Jacobi D; Liu S; Bhargava P; Dai L; Gangl MR; Inouye K; Barlow JL; Ji Y; Mizgerd JP et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Epithelial cell-specific Act1 adaptor mediates interleukin-25-dependent helminth expulsion through expansion of Lin(-)c-Kit(+) innate cell population.

Immunity
2012-05 | Journal article
Contributors: Kang Z; Swaidani S; Yin W; Wang C; Barlow JL; Gulen MF; Bulek K; Do JS; Aronica M; McKenzie AN et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Blocking IL-25 signalling protects against gut inflammation in a type-2 model of colitis by suppressing nuocyte and NKT derived IL-13.

Journal of gastroenterology
2012-04 | Journal article
Contributors: Camelo A; Barlow JL; Drynan LF; Neill DR; Ballantyne SJ; Wong SH; Pannell R; Gao W; Wrigley K; Sprenkle J et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Transcription factor RORα is critical for nuocyte development.

Nature immunology
2012-01 | Journal article
Contributors: Wong SH; Walker JA; Jolin HE; Drynan LF; Hams E; Camelo A; Barlow JL; Neill DR; Panova V; Koch U et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Insights into the initiation of type 2 immune responses.

Immunology
2011-12 | Journal article
Contributors: Oliphant CJ; Barlow JL; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Innate IL-13-producing nuocytes arise during allergic lung inflammation and contribute to airways hyperreactivity.

The Journal of allergy and clinical immunology
2011-11 | Journal article
Contributors: Barlow JL; Bellosi A; Hardman CS; Drynan LF; Wong SH; Cruickshank JP; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Reciprocal expression of IL-25 and IL-17A is important for allergic airways hyperreactivity.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2011-07 | Journal article
Contributors: Barlow JL; Flynn RJ; Ballantyne SJ; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Nuocytes: expanding the innate cell repertoire in type-2 immunity.

Journal of leukocyte biology
2011-06 | Journal article
Contributors: Barlow JL; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Tim1 and Tim3 are not essential for experimental allergic asthma.

Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology
2011-04 | Journal article
Contributors: Barlow JL; Wong SH; Ballantyne SJ; Jolin HE; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

New insights into 5q- syndrome as a ribosomopathy.

Cell cycle (Georgetown, Tex.)
2010-11 | Journal article
Contributors: Barlow JL; Drynan LF; Trim NL; Erber WN; Warren AJ; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Tim-1 is induced on germinal centre B cells through B-cell receptor signalling but is not essential for the germinal centre response.

Immunology
2010-05 | Journal article
Contributors: Wong SH; Barlow JL; Nabarro S; Fallon PG; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Induction of p53 and up-regulation of the p53 pathway in the human 5q- syndrome.

Blood
2010-04 | Journal article
Contributors: Pellagatti A; Marafioti T; Paterson JC; Barlow JL; Drynan LF; Giagounidis A; Pileri SA; Cazzola M; McKenzie AN; Wainscoat JS et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

C-type lectin SIGN-R1 has a role in experimental colitis and responsiveness to lipopolysaccharide.

Journal of immunology (Baltimore, Md. : 1950)
2010-02 | Journal article
Contributors: Saunders SP; Barlow JL; Walsh CM; Bellsoi A; Smith P; McKenzie AN; Fallon PG
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

A p53-dependent mechanism underlies macrocytic anemia in a mouse model of human 5q- syndrome.

Nature medicine
2009-11 | Journal article
Contributors: Barlow JL; Drynan LF; Hewett DR; Holmes LR; Lorenzo-Abalde S; Lane AL; Jolin HE; Pannell R; Middleton AJ; Wong SH et al.
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

IL-25: a key requirement for the regulation of type-2 immunity.

BioFactors (Oxford, England)
2009-03 | Journal article
Contributors: Barlow JL; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

The C-type lectin SIGNR1 binds Schistosoma mansoni antigens in vitro, but SIGNR1-deficient mice have normal responses during schistosome infection.

Infection and immunity
2008-11 | Journal article
Contributors: Saunders SP; Walsh CM; Barlow JL; Mangan NE; Taylor PR; McKenzie AN; Smith P; Fallon PG
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Blocking IL-25 prevents airway hyperresponsiveness in allergic asthma.

The Journal of allergy and clinical immunology
2007-09 | Journal article
Contributors: Ballantyne SJ; Barlow JL; Jolin HE; Nath P; Williams AS; Chung KF; Sturton G; Wong SH; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central

Identification of an interleukin (IL)-25-dependent cell population that provides IL-4, IL-5, and IL-13 at the onset of helminth expulsion.

The Journal of experimental medicine
2006-04 | Journal article
Contributors: Fallon PG; Ballantyne SJ; Mangan NE; Barlow JL; Dasvarma A; Hewett DR; McIlgorm A; Jolin HE; McKenzie AN
Source: Self-asserted source
JL Barlow; Jillian L Barlow; via Europe PubMed Central